Skip to main content

Pain Management Market Treatment Analysis by Type and Professional Insights 2019 to 2023

The global pain management market Size is predicted to grow at a 6.0% CAGR over the forecast period (2018-2023), Market Research Future (MRFR) report.

Pain can be frustrating and debilitating and can interfere with activities, time with family and friends, work, and sleep. Pain management Device Industry can offer relief so people can enjoy life. Pain management Devices Market is a medical specialty that is growing rapidly and takes a multi-disciplinary approach to treat all forms of pain. This covers a huge spectrum of conditions such as post-operative pain, sciatica, neuropathic pain, and others. Various factors are propelling the pain management market growth.
These factors, as stated by the MRFR report, include increasing technological advancements, rising prevalence of cancer pain, improved reimbursement policies, especially in developed countries, and improving regulatory framework.
Major Market Players Competitive Dashboard:
Teva Pharmaceuticals
Stryker Corporation
Sanofi
Purdue Pharma LP
Novartis AG
Merck & Co. Inc.
Nevro Corp.
Dickinson and Company
Becton
Neurotech Na Inc.
Braun Melsungen AG
Smiths Medical
Halyard Health Inc.
Pfizer Inc.
Boston Scientific Corporation
Jude Medical Inc.
Medtronic PLC
Mallinckrodt plc
Johnson & Johnson Services Inc.
GlaxoSmithKline plc
Forest Laboratories
Hoffmann-La Roche Ltd
Endo Health Solutions
Eli Lilly & Company
DJO Global LLC
Codman And Shurtleff Inc
Bayer AG
AstraZeneca plc
Astellas Pharma
Allergan
Abbvie
Abbott Laboratories
and others.
Pain Management Industry Segmentation:
The Market Global pain management market wide segmental analysis based on end user, mode of purchase, indication, type of pain management drugs, and type of pain management devices.
Based on pain management devices, the pain management market is segmented into ablation devices, analgesic infusion pumps, and neurostimulation devices. The neurostimulation device is again segmented into spinal cord stimulation (SCS) and transcutaneous electrical nerve stimulation (TENS) devices.
Based on the type of pain management drugs, the pain management market is segmented into antidepressants, antimigraine agents, opioids, anesthetics, anticonvulsants, non-steroidal anti-inflammatory drugs (NSAIDS), and others. The opioids segment is again segmented into methadone, meperidine, fentanyl, codeine, tramadol, hydrocodone, oxycodone, and others.
Based on indication, the pain management market is segmented into post-operative pain, migraine, arthritic pain, chronic back pain, fibromyalgia, musculoskeletal pain, facial pain, cancer pain, neuropathic pain, and others. Of these, the neuropathic pain segment will dominate the market over the forecast period.
Based on the mode of purchase, the pain management market is segmented into prescription-based and over the counter.
Based on end user, the pain management market is segmented into research and academic institutes, medical device companies, pharmaceutical companies, hospitals and clinics, and others.
Pain Management Market Regional Analysis:
Based on the region, the pain management market report covers growth opportunities and the latest trends across Europe, the Americas, the Asia Pacific, and the Middle East and Africa. Of these, the Americas will lead the market over the forecast period. This is owing to the growing prevalence of chronic pain, high health expenditure, well-developed technology, and the presence of various leading players in the region.
The pain management market in Europe is predicted to have the second-largest share in the market over the forecast period. This is owing to the rising competition among marketers and rising contribution towards R&D.
The pain management market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is owing to increasing healthcare expenditure, a huge patient pool, and rising demand for treatments.
The pain management market in the Middle East and Africa will have the lowest share in the market over the forecast period. This is owing to poor medical facilities, lack of technical knowledge, and low development in the region.
About Market Research Future: Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune – 411028
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...
Post a Comment
Read more

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...
Post a Comment
Read more

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

  Global Merkel Cell Carcinoma Market  Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth.  Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...
Post a Comment
Read more